ArticleFrontiers in pharmacology2022

Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors.

Shayma El-Atawneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.